3,249 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 584 funds opening new positions, 1,250 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,250 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.25%67.22% (+0.97%)

Holders
3,249
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
2001
$1.14M
2002
$1.14M
2003
$1.13M
2004
$1.13M
2005
$1.13M
2006
$1.13M
2007
$1.13M
2008
$1.13M
2009
$1.13M
2010
$1.13M
2011
$1.12M
2012
$1.12M
2013
$1.12M
2014
$1.12M
2015
$1.12M
2016
$1.11M
2017
$1.11M
2018
$1.11M
2019
$1.11M
2020
$1.11M
2021
$1.11M
2022
$1.11M
2023
$1.11M
2024
$1.1M
2025
$1.1M